Project Grant R01DA065598
Award Date 6/1/26
Completion Date 3/31/31
Dollars Obligated $669K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Washington a $1.447 million Project Grant on September 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and validate practical, scalable strategies for identifying opioid use disorder (OUD) and engaging incarcerated individuals in medication for opioid use disorder (MOUD) treatment. The project addresses a critical public health gap, as individuals released...
- Federal Grant Award Summary The University of Washington received a $4.665 million Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective June 15, 2025, through May 31, 2029. This grant supports the development and testing of the Community-Based Opioid Treatment (CBOT) implementation strategy, a nurse-led care delivery model designed to provide buprenorphine and HIV prevention and care services to people who...
- Federal Grant Award Summary The University of Washington received a $672,701 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded on February 15, 2026, with a completion date of November 30, 2030. The research project, conducted at Harborview Medical Center in Seattle, focuses on implementing HIV screening and prevention services within low-barrier office-based opioid treatment (OBOT) programs. The initiative...
- Federal Project Grant Award Summary The University of Washington, under sponsorship of the National Institute on Drug Abuse (NIDA) through the Drug Use and Addiction Research Programs (CFDA 93.279), received a $2.33 million Project Grant award on August 15, 2025, to conduct a hybrid implementation-effectiveness study of a pharmacist-led collaborative care model for hepatitis C (HCV) treatment among persons who use drugs with housing insecurity. The study will be conducted in Seattle and King...
- Federal Project Grant Award Summary The University of Washington received a $100,228 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded November 10, 2026, with a completion date of June 15, 2029. This F31 Fellowship award funds doctoral-level research characterizing the role of endogenous nociceptin opioid release from the central amygdala in reward outcome encoding. The research directly addresses NIDA...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded University of Colorado-Denver a $709,085 Project Grant effective April 1, 2026, through January 31, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). This implementation trial will develop and test a facilitation intervention to increase in-hospital opioid treatment program (OTP) intake completion among hospitalized patients with opioid use disorder (OUD). The study employs a novel...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Washington a project grant of $139,812.00 under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct basic neuroscience research examining the molecular mechanisms underlying stress-induced vulnerability to substance use disorders. The research, titled "Serotonin and Dopamine Dynamics During Kappa Opioid Mediated Aversion," investigates how kappa opioid receptor...
- Federal Grant Award Summary New York University School of Medicine received a $771,043 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective March 15, 2026, with completion targeted for December 31, 2030. The award funds a hybrid Type II implementation-effectiveness trial designed to evaluate a peer change agent intervention—termed LINKED (Leveraging Interpersonal Networks to Keep Engagement in PrEP...
- Federal Grant Award Summary The University of Miami's Office of Research Administration received a $109,652 Project Grant award on August 19, 2026, from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct implementation research on comprehensive telehealth models addressing HIV and Substance Use Disorder (SUD) among people who inject drugs (PWID). The study directly supports the Ending the HIV Epidemic (EHE) Initiative's goal to reduce...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Maryland, Baltimore a Project Grant of $219,291 under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 30, 2025, for implementation of the Integrated Services for People Who Inject Drugs (PWID) Using Person-Centered Interactions, Reach, and Engagement (INSPIRE) study. This three-year initiative (completion date July 31, 2028) addresses critical gaps in HIV prevention and...